| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.893 | 7.185 | 9.663 | 8.980 | 12.884 | 13.602 | 15.124 | 44.662 | 44.151 | 44.429 |
| Total Income - EUR | 5.893 | 7.185 | 9.663 | 8.980 | 12.884 | 13.602 | 15.124 | 44.667 | 44.158 | 44.434 |
| Total Expenses - EUR | 6.200 | 7.307 | 9.857 | 9.308 | 12.829 | 13.535 | 16.500 | 20.987 | 30.444 | 35.424 |
| Gross Profit/Loss - EUR | -307 | -122 | -194 | -328 | 55 | 68 | -1.377 | 23.679 | 13.715 | 9.010 |
| Net Profit/Loss - EUR | -483 | -266 | -291 | -417 | -74 | -206 | -1.528 | 23.289 | 13.339 | 7.743 |
| Employees | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Rheumaoculo Center S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.640 | 1.319 | 997 | 685 | 384 | 94 | 0 | 0 | 0 | 0 |
| Current Assets | 889 | 1.188 | 1.325 | 1.349 | 1.387 | 1.571 | 177 | 19.583 | 15.859 | 9.983 |
| Inventories | 831 | 1.071 | 1.053 | 1.221 | 1.197 | 1.430 | 0 | 0 | 0 | 0 |
| Receivables | 1 | 0 | 114 | 112 | 110 | 108 | 166 | 300 | 151 | 105 |
| Cash | 58 | 117 | 158 | 16 | 80 | 34 | 11 | 19.283 | 15.709 | 9.878 |
| Shareholders Funds | -6.128 | -6.331 | -6.515 | -6.812 | -6.754 | -6.832 | -8.209 | 15.055 | 13.995 | 7.792 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.657 | 8.838 | 8.837 | 8.846 | 8.525 | 8.498 | 8.386 | 4.528 | 1.864 | 2.192 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Rheumaoculo Center S.r.l.